Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Emerging Themes and Technologies in Tissue Engineering and Bioprinting

Ibrahim Ozbolat's Biography



Ibrahim Ozbolat, Associate Professor, The Huck Institutes of the Life Sciences, Penn State University

Dr. Ozbolat is Associate Professor, Engineering Science and Mechanics, The Huck Institutes of the Life Sciences, Penn State University. He received his Ph.D from the University at Buffalo, New York, and dual B.S. degrees in Mechanical Engineering and in Industrial Engineering from Middle East Technical University, Turkey. Dr. Ozbolat's major research thrust is in the area of Biomanufacturing and Tissue Engineering with a special focus on 3D Bioprinting, particularly bioprinting for organ fabrication. His current research focuses on development of novel bioprinting science and technology for various areas in regenerative medicine including bioprinting of pancreatic organs for type-1 diabetes, vascular tissue printing, in-situ bone printing and gel-free cartilage printing. He has published over 70 journal and conference articles, and his research has been featured in local, national and international media, broadcast TVs and press numerous times. He is the founder of two spin-off companies and received several prestigious international awards.

Ibrahim Ozbolat Image

Multi-Arm Bioprinting: From Perfusable Tissues to in-situ Bioprinted Tissues

Monday, 9 February 2015 at 13:30

Add to Calendar ▼2015-02-09 13:30:002015-02-09 14:30:00Europe/LondonMulti-Arm Bioprinting: From Perfusable Tissues to in-situ Bioprinted TissuesSELECTBIOenquiries@selectbiosciences.com

This talk highlights the recent advances in extrusion-based advanced bioprinting technologies using multi-arm bioprinting. The Multi-Arm BioPrinter (MABP) created at The University of Iowa enables synchronized motion of multiple arms in tandem to bioprint multiple bioink at the same time. The MABP is flexible to be equipped with different nozzle apparatus for various purposes including vascular tissue printing, hybrid tissue scaffold printing, scaffold-free vascularized perfusable tissue printing and in-situ multi-arm bioprinting. In this talk, we will emphasize recent significant capabilities including vascularized perfusable tissue printing for drug testing and in-situ bioprinting of bone tissue for translation of advanced robotics technologies from bench to bedside.


Add to Calendar ▼2015-02-09 00:00:002015-02-10 00:00:00Europe/LondonEmerging Themes and Technologies in Tissue Engineering and BioprintingSELECTBIOenquiries@selectbiosciences.com